KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index

Q1 2026 earnings release scheduled; analysts forecast EPS of $2.93 estimated. Expected medium impact (5%) as earnings are a key driver for stock valuation; scheduled.

Fourth quarter and full-year fiscal 2026 financial results and conference call scheduled.

MetLife is scheduled to release its first quarter 2026 financial results after the market closes on May 6, 2026, with a conference call to follow on May 7, 2026. This is a future event, and its impact is estimated as High due to the significance of earnings reports on stock valuation; scheduled.

First quarter 2026 earnings results and conference call for 2026-05-06. Medium importance estimated as earnings reports typically drive moderate market reactions, scheduled.

First-quarter 2026 financial results scheduled to be announced after the market closes on 2026-05-04. Estimated 5% impact based on historical volatility during earnings releases scheduled.

Q1 2026 earnings release is scheduled for 2026-05-01. Analysts forecast EPS of $1.47. Medium importance is estimated due to potential volatility scheduled.

First quarter 2026 earnings results and conference call scheduled for May 1, 2026; estimated 1% price impact scheduled.

ConocoPhillips is scheduled to release its Q1 2026 financial results before the market opens on April 30, 2026. High importance is estimated as earnings reports typically cause significant price volatility, scheduled

Amgen is scheduled to report its Q1 2026 financial results after the market closes on April 30, 2026, scheduled. Earnings reports for major pharmaceutical companies typically result in price movements exceeding 5%.

Bristol-Myers Squibb is scheduled to announce its Q1 2026 financial results on April 30, 2026, before the market opens, followed by a conference call with the investment community; a Medium importance is estimated as earnings releases typically impact stock prices by at least 5%, scheduled.

The Cigna Group is scheduled to release its first-quarter 2026 financial results on April 30, 2026, before the market opens. Analysts forecast EPS of $7.57. Earnings releases typically cause significant price movement (estimated >5% impact). scheduled

Illinois Tool Works is scheduled to release its Q1 2026 financial results on April 30, 2026, before the market opens. Estimated impact is Medium as earnings reports typically drive significant price movement for industrial stocks scheduled.

Merck is scheduled to announce its Q1 2026 financial results and hold a conference call with investors and analysts on April 30, 2026; analysts estimate a price impact of at least 5%, estimated.

Q1 2026 earnings release scheduled

Quarterly dividend of $1.42 per share, ex-dividend date is 2026-04-30 scheduled. Market impact is estimated at ≥1% due to the dividend yield's influence on stock price.

Automatic Data Processing (ADP) is scheduled to release its financial results for the third fiscal quarter of 2026 before the market opens on April 29, 2026, followed by a conference call. Medium importance is estimated as earnings releases typically trigger price movements of 5% or more, scheduled

Qualcomm's second-quarter fiscal 2026 earnings release and conference call on April 29, 2026. This is estimated to have a low impact (>=1%) as a routine financial disclosure, scheduled.

First quarter 2026 earnings and quarterly dividend information to be released on April 28, 2026, scheduled. Importance is estimated as High as earnings results for asset managers often have a significant market impact.

United Parcel Service is scheduled to announce its Q1 2026 financial results on April 28, 2026, before the market opens; high importance is estimated as earnings reports typically drive significant price movement, scheduled.

Q1 2026 earnings release scheduled for before market open on April 28, 2026. Quarterly results for major consumer goods companies often lead to moderate price adjustments (estimated >5% impact) scheduled.

Mondelez International will release its first quarter 2026 financial results on April 28, 2026. Market reaction expected to be significant based on historical volatility, scheduled.

Sysco is scheduled to announce its third quarter fiscal year 2026 financial results on April 28, 2026, scheduled.

Procter & Gamble is scheduled to release its Q3 Fiscal Year 2026 earnings results and hold a conference call on April 24, 2026, an event analysts are watching for signs of U.S. market share stabilization. This event is scheduled.

Comcast is scheduled to release its Q1 2026 earnings results on April 23, 2026, with analysts forecasting an EPS of $0.72; a 5% price impact is estimated based on historical earnings volatility, scheduled.

First quarter 2026 earnings release scheduled for 2026-04-22. Analysts forecast quarterly earnings of $3.20 per share on revenues of $1.78 billion. High importance reflects potential volatility from earnings surprises, estimated.

Q1 2026 earnings release is scheduled for 2026-04-22. Analysts forecast earnings of $1.56 per share and revenue of $4.85 billion forecasted. Market impact is estimated at ≥1% as earnings releases typically drive moderate volatility.

UnitedHealth Group is scheduled to release its first quarter 2026 financial results on April 21, 2026. This is the first earnings report under new CEO Stephen Hemsley and is highly anticipated by investors for updates on the company's margin recovery strategy, which is expected to cause significant price volatility, scheduled.

Medium importance estimated due to expected market volatility. Analysts forecast EPS of $1.44 estimated. First quarter 2026 earnings release scheduled.

Regions Financial Corp is scheduled to report its first-quarter 2026 financial results on April 17, 2026. Analysts forecast EPS of $0.60 and revenue of $1.92 billion. High importance is estimated as earnings surprises in the banking sector often trigger price movements exceeding 10%, scheduled.

State Street Corporation is scheduled to announce its first-quarter 2026 financial results on April 17, 2026. Analysts forecast year-over-year growth in earnings and revenue; medium importance estimated based on historical earnings volatility scheduled.

Abbott is scheduled to announce its Q1 2026 financial results on April 16, 2026, before the market opens; analysts forecast EPS of $1.15 and revenue of $11.0 billion; earnings releases typically result in a ~5% price impact scheduled.

PepsiCo is scheduled to release its Q1 2026 financial results on April 16, 2026; analysts forecast earnings of $1.55 per share and revenue of $18.9 billion scheduled. Medium importance reflects typical price volatility around earnings releases.

Ex-dividend date (2026-04-16) for a quarterly cash dividend of $1.02 per share, announced on February 24, 2026. Low importance estimated as dividend-related price adjustments are usually minor, scheduled.

Annual meeting of stockholders scheduled for 2026-04-16 scheduled. Market impact is estimated at ≥1% as shareholder meetings can reveal strategic updates.

Announced plans to expand its Equity Index Dividend suite with new options and futures products, scheduled to launch on May 11, 2026, pending regulatory review, scheduled.

BTIG Research upgraded Mondelez International to a "strong-buy" rating on April 15, 2026.

On April 15, 2026, the Board of Directors declared a quarterly cash dividend of $0.265 per common share, payable on July 1, 2026, to stockholders of record on June 1, 2026.

On April 14, 2026, it was reported that the US FDA refused to file partner Replimune's application for its drug RP1 in combination with Bristol Myers Squibb's Opdivo for advanced melanoma, citing concerns about the study design.

Appointment of a new Global Chief People Officer, effective April 14, 2026. Secondary executive appointments typically have minimal impact on share price (estimated >1% impact) scheduled.

On April 14, 2026, MetLife announced its recommendation for shareholders to reject an unsolicited 'mini-tender' offer from Potemkin Limited to purchase shares at $44.20, a price approximately 41% below the market price on April 13, 2026.

The company's Board of Directors announced a quarterly dividend increase to $1.0885 per share on April 14, 2026, marking its 70th consecutive year of dividend increases.

CEO announced that the company has filed paperwork with the Federal Energy Regulatory Commission (FERC) for its Constitution natural gas pipeline project, with a target in-service date of winter 2027. Estimated 1% impact as regulatory progress is a long-term positive expected.

Nicholas Fink officially took the helm as the new President and CEO on April 13, 2026, succeeding Bill Newlands as part of a previously announced succession plan.

Strategic asset swap with Venezuela's PDVSA on April 13, 2026, to increase stake in Petroindependencia to 49% and develop the Ayacucho 8 block; estimated 5% price impact expected.

The U.S. FDA is expected to accept and grant Priority Review for the Biologics License Application for ifinatamab deruxtecan on April 13, 2026, with a decision date set for October 10, 2026; analysts estimate a price impact of at least 5%, estimated.

CEO Elliott Hill and board member Tim Cook purchased approximately $1 million and $3 million worth of NKE stock, respectively. These large insider buys on April 10 and April 13 were viewed as a signal of leadership's confidence in the company's turnaround.

Announced March 2026 month-end assets under management of $1.71 trillion, with net outflows of $3.2 billion for the month and $13.7 billion for the first quarter of 2026

Ex-dividend date for an increased quarterly cash dividend of $0.47 per share on 2026-04-13, representing the 63rd consecutive quarterly increase. Low importance estimated as dividend changes typically have minor immediate price impact.

Reported preliminary assets under management (AUM) of $173.0 billion as of March 31, 2026, on April 10, 2026, representing a decrease from the previous month.

Qualcomm and Snap's subsidiary, Specs Inc., announced a multi-year strategic partnership on April 10, 2026, to develop future augmented reality (AR) 'Specs' glasses powered by Snapdragon platforms, with a new version scheduled for a 2026 launch. This partnership is estimated to have a medium impact (>=5%) as it strengthens Qualcomm's position in the growing AR market.

Quarterly dividend of $1.50 per share went ex-dividend on April 9, 2026. The dividend is payable on May 1, 2026, to shareholders of record as of April 10, 2026.